Literature DB >> 21153908

Molecular modeling study of intercalation complexes of tricyclic carboxamides with d(CCGGCGCCGG)₂ and d(CGCGAATTCGCG)₂.

Athanasia Varvaresou1, Kriton Iakovou.   

Abstract

Tricyclic dyes with different mesoatoms such as xanthenes (fluorescein, eosin) anthracenes and acridines (proflavine) approved by the Food and Drug Administration (FDA) for use in foods, pharmaceuticals and cosmetic preparations interact with DNA, and some of them do so through intercalation. Hyperchem 7.5, Spartan 04, Yasara 10.5.14 program packages and molecular modeling, molecular mechanics and dynamics techniques with the oligonucleotides d(CCGGCGCCGG)2 and d(CGCGAATTCGCG)2 were utilized in order to examine the mode of binding to DNA of a range of tricyclic carboxamides bearing N,N-dimethylaminoethyl side chain, i.e., 9-amino-DACA, anthracene, acridine-1-carboxamide, acridine-4-carboxamide (DACA), azacridine, phenazine, pyridoquinoxaline, oxopyridoquinoxaline, phenoxazine and xanthenone or N,N-dimethylaminobutyl moiety, i.e., phenazine and acridine. The bicyclic quinoline-8-carboxamide was also examined for comparison reasons. On the basis of our data, prerequisite for the interaction between protonated N,N-dimethylaminoethyl moiety and guanine is the formation of only one internal hydrogen bond between carboxamide and peri NH + in the case of 9-amino-DACA or peri N in the cases of DACA, azacridine, phenazine and pyridoquinoxaline. The presence of an additional internal hydrogen bond between oxygen carboxamide and protonated N,N-dimethylamino group in the cases of tricyclic systems bearing peri NH (phenoxazine) or O (xanthenone) group, prevents the interaction between side chain and guanine. Also, the formation of one internal hydrogen bond between oxygen carboxamide and protonated N,N-dimethylamino group inhibits the interaction between side chain and guanine in the case of acridine-1-carboxamide. Our findings are in accordance with previously reported results obtained from the kinetic studies of the binding of acridine and related tricyclic carboxamides to DNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21153908     DOI: 10.1007/s00894-010-0891-5

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  32 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

2.  Evidence for sequence preferences in the intercalative binding of ethidium bromide to dinucleoside monophosphates.

Authors:  T R Krugh; C G Reinhardt
Journal:  J Mol Biol       Date:  1975-09-15       Impact factor: 5.469

3.  Bioactive principles in the bark of Pilidiostigma tropicum.

Authors:  William N Setzer; Glenn F Rozmus; Mary C Setzer; Jennifer M Schmidt; Bernhard Vogler; Sabine Reeb; Betsy R Jackes; Anthony K Irvine
Journal:  J Mol Model       Date:  2006-04-07       Impact factor: 1.810

4.  Making optimal use of empirical energy functions: force-field parameterization in crystal space.

Authors:  Elmar Krieger; Tom Darden; Sander B Nabuurs; Alexei Finkelstein; Gert Vriend
Journal:  Proteins       Date:  2004-12-01

5.  Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.

Authors:  Laurence P G Wakelin; Adrienne Adams; William A Denny
Journal:  J Med Chem       Date:  2002-02-14       Impact factor: 7.446

6.  Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations.

Authors:  G J Kapadia; H Tokuda; R Sridhar; V Balasubramanian; J Takayasu; P Bu; F Enjo; M Takasaki; T Konoshima; H Nishino
Journal:  Cancer Lett       Date:  1998-07-03       Impact factor: 8.679

7.  Molecular modeling of tricyclic compounds with anilino substituents and their intercalation complexes with DNA sequences.

Authors:  Marco A Loza-Mejía; Rafael Castillo; Alfonso Lira-Rocha
Journal:  J Mol Graph Model       Date:  2009-02-12       Impact factor: 2.518

8.  Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.

Authors:  G J Atwell; G W Rewcastle; B C Baguley; W A Denny
Journal:  J Med Chem       Date:  1987-04       Impact factor: 7.446

9.  New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.

Authors:  Miguel F Braña; Mónica Cacho; Mario A García; Beatriz de Pascual-Teresa; Ana Ramos; M Teresa Domínguez; José M Pozuelo; Cristina Abradelo; María Fernanda Rey-Stolle; Mercedes Yuste; Mónica Báñez-Coronel; Juan Carlos Lacal
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

10.  Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.

Authors:  E Schneider; S J Darkin; P A Lawson; L M Ching; R K Ralph; B C Baguley
Journal:  Eur J Cancer Clin Oncol       Date:  1988-11
View more
  3 in total

1.  From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy.

Authors:  Leslie O Ofori; Jason Hoskins; Masayuki Nakamori; Charles A Thornton; Benjamin L Miller
Journal:  Nucleic Acids Res       Date:  2012-04-06       Impact factor: 16.971

Review 2.  An overview of recent advances in duplex DNA recognition by small molecules.

Authors:  Sayantan Bhaduri; Nihar Ranjan; Dev P Arya
Journal:  Beilstein J Org Chem       Date:  2018-05-16       Impact factor: 2.883

3.  YM155 inhibits topoisomerase function.

Authors:  Mei Hong; Ming-Qiang Ren; Jeane Silva; Ananya Paul; W David Wilson; Carsten Schroeder; Paul Weinberger; John Janik; Zhonglin Hao
Journal:  Anticancer Drugs       Date:  2017-02       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.